World News

Indonesia to receive US vaccines in COVID emergency | Coronavirus pandemic News

[ad_1]

Four million doses of the Modern U.S. COVID-19 vaccine are going to Indonesia, the U.S. national security adviser has told the Indonesian foreign minister that the fighting in the countries records coronavirus infections and forced deaths. emergency shutdown starting Saturday.

In a call with Retno Marsudi on Friday, Jake Sullivan said the doses will be sent through the COVAX general vaccine sharing program “as soon as possible,” in a White House note.

Sullivan said the donation “underscores the support that the United States has given to the people of Indonesia because they are fighting the floods in the COVID-19 cases.”

The two officials also discussed plans to increase support for greater efforts in Indonesia’s COVID-19 response, the document said.

“Sullivan highlighted the importance of the Biden-Harris administration in Indonesia, Southeast Asia and the end of the pandemic and promised a high level of support and commitment,” he promised.

Indonesia is the fourth most populous country in the world and has fought one of the most serious outbreaks of Asian coronaviruses.

The nation has registered eight new infections in the last 12 days, with 25,830 new cases and 539 deaths on Friday.

In Jakarta province alone, Governor Anies Baswedan said in a press conference on Friday that the number of active cases has already risen from 27,000 to 78,000 in February.

Anies said if the trend continues, active cases could reach 100,000 people in a few days.

Since the pandemic last year, Indonesia has had a total of 2,228,938 cases and 59,534 deaths.

The rise in new cases and deaths has prompted President Joko Widodo to declare emergency movement limits on the island of Java and Bali on Saturday. The lock will remain in effect until July 20.

Competing for vaccine diplomacy

Penny K Lukito, head of the Indonesian food and drug agency, said on Friday that he had allowed Moderna to vaccinate for emergencies.

Meanwhile, the country’s health minister announced on Friday that Indonesia intends to integrate the challenge developed by Pfizer and BioNTech with coronavirus mRNA under the age of 18.

Budi Gunadi Sadikin said that half of the more than 270 million people in the country live on the island of Java, which was the largest occurrence of the highly contagious Delta variant of COVID-19. The Indian variant was first identified.

The Pfizer-BioNTech vaccine is seen to be as effective as 84 percent, even with the Delta variant, after two doses, but only 34 percent is effective with a single dose, the NBC Boston U.S. website reported.

Modern also reported on Tuesday that its vaccine had shown promise against the Delta variant, based on a study of blood serum by eight participants who received a second dose of the vaccine a week later.

The company said the vaccine was much more effective in producing antibodies against the Delta variant against the Beta variant first identified in South Africa.

Indonesia is mainly based on the Chinese Sinovac vaccine, but has sought to diversify sources of supply.

Washington has competed with Beijing to deepen its geopolitical flavor through so-called vaccine diplomacy, but said it does not share vaccines for benefits or concessions, but to save lives and end the pandemic.

The Biden administration pledged to share 80 million vaccines in the United States last month around the world over the difference in vaccine rates between advanced and developing countries.

It has already announced plans to vaccinate other countries in Southeast Asia – the Philippines, Vietnam, Thailand, Laos, Papua New Guinea and Cambodia.

He also said he would buy 500 million Pfizer / BioNTech vaccines from the African Union and distribute them to 92 low- and middle-income countries.



[ad_2]

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button